Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0432222 (SEM)
 47,337 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Neutrophils (PMN) are important in the cellular phase of blood fibrino lytic activity (FA). The contribution of monocytes (MC), which have FA, is unclear. To determine the relative roles of these cells to activity in normal blood, we examined, by solid phase radiofibrin assay, FA of normal blood and plasma, and of purified PMN and MC, with and without plasminogen (PLG), mini-plasminogen (mPLG), the other major elastase fragment of PLG, or autologous plasma. PMN alone (0.5 x 10(6)/ml) had striking activity (292 +/- 25 SEM ng fibrin lysed/h; n = 10 normal subjects) while MC alone (0.5 x 10(6)/ml) had mean FA of 32 +/- 4 ng/h, which could be accounted for by contaminating PMN (36 +/- 8 ng/h). Thus, in a 1 h assay (when cellular FA accounts for 70-80% of FA in whole blood), normal numbers of MC (0.5 x 10(6)/ml) had no detectable FA when assayed with PLG or normal plasma. With longer assay times (2-6 h), PLG-dependent (plasminogen activator, PA) activity was demonstrated with mixtures of MC and PLG or plasma. This PA activity was released into the medium and required prior contact of MC and an intact, soluble PLG molecule for PA activity to be detected in medium (suggesting a PLG-MC triggering mechanism), since activity was reduced or absent when MC were exposed to mPLG, the other major elastase fragment of PLG, or solid phase PLG. Exposure of MC to solid phase fibrin did not result in PA release. MC PA activity was little affected by cycloheximide pretreatment, indicating preformed rather than newly synthesized PA. By SDS-PAGE and fibrin zymography, MC extracts revealed a single PA band with features of pro-urokinase (single chain urinary-type PA): Mr 55,000, inhibition by antiurokinase antibody (but not by anti-tPA), and resistance to inhibition by DFP. By ELISA assay, approximate normal monocyte content of this PA (as Mr 55,000 urokinase) was 0.03 fg (3.3 x 10(8) molecules) per cell.
 ...
PMID:Fibrinolytic activity of normal human blood monocytes. 292 5

Because the terminal sialic acid of several glycoproteins regulates their intravascular half-life, and because asialo platelets have a shortened survival, we postulated that asialo platelets might affect the basal rate of thrombopoiesis. Thrombopoiesis was measured by the incorporation of intravenous 75Se-selenomethionine (a cohort label) into circulating rabbit platelets. Each animal acted as its own control. In one control group, saline was injected intravenously once daily for two days. 75Se-selenomethionine was then injected, 15 microCi/kgm on day 2 and platelets harvested on day 5 for measurement of specific activity (S.A.), cpm/10(7) platelets. The animals were allowed to rest for two weeks, and the experiment repeated. The ratio of the second SA over the first SA was utilized as the stimulation index. When saline was injected the second time, the stimulation index was 1.22 +/- 0.07 (SEM) in eight animals. Asialo platelets were prepared by incubating washed platelets with neuraminidase, 2 units/ml for 60 min. Injection of 2-4 X 10(9) asialo platelets/kgm (the second time) resulted in a stim. index of 2.08 +/- 0.23 (P less than 0.001) in 11 animals. Similar results were obtained with 1 mM DFP and neuraminidase (12 animals). Negative results were obtained when 11 rabbits were injected with a comparable number of untreated washed platelets, stim. index 1.07 +/- 0.13; when 10 rabbits were injected with sonicated asialo platelets, stim. index 1.10 +/- 0.12; or when four rabbits were injected with platelets treated with chymotrypsin, 3 mg/ml for 45 min, stim. index 0.80 +/- 0.04. We conclude that asialo intact platelets stimulate megakaryocytes to produce more platelets. It is suggested that the basal stimulus to thrombopoiesis may be regulated by desialidated older platelets.
 ...
PMID:Asialo platelets enhance thrombopoiesis. 724 77